BHVN

BHVN

USD

Biohaven Ltd. Common Shares

$13.950-0.660 (-4.517%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$14.610

High

$14.815

Low

$13.650

Volume

33.60M

Company Fundamentals

Market Cap

1.5B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

2.28M

Exchange

NYQ

Currency

USD

52-Week Range

Low $12.79Current $13.950High $54.98

Related News

PR Newswire

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and...

View more
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
PR Newswire

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and...

View more
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia